Nektar Therapeutics
NKTR
$1.32
Share price
0.00%
Change (1 day)
76.00%
Change (1 year)
Categories
Nektar Therapeutics (NKTR) - Total assets
Total assets on the balance sheet as of December 2023 : $0.39 B
According to Nektar Therapeutics 's latest financial reports the company's total assets are $0.39 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Nektar Therapeutics - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.39 B | -43.99% |
| 2022-12-31 | $0.71 B | -36.39% |
| 2021-12-31 | $1.11 B | -27.4% |
| 2020-12-31 | $1.53 B | -22.18% |
| 2019-12-31 | $1.97 B | -8.04% |
| 2018-12-31 | $2.15 B | 322.54% |
| 2017-12-31 | $0.50 B | -10.55% |
| 2016-12-31 | $0.56 B | 14.08% |
| 2015-12-31 | $0.49 B | 12.91% |
| 2014-12-31 | $0.44 B | 1.63% |
| 2013-12-31 | $0.43 B | -12.71% |
| 2012-12-31 | $0.49 B | -17.93% |
| 2011-12-31 | $0.60 B | 16.37% |
| 2010-12-31 | $0.52 B | -9.43% |
| 2009-12-31 | $0.57 B | 2.67% |
| 2008-12-31 | $0.56 B | -22.7% |
| 2007-12-31 | $0.72 B | -5.61% |
| 2006-12-31 | $0.76 B | -10.53% |
| 2005-12-31 | $0.85 B | 15.25% |
| 2004-12-31 | $0.74 B | 20.77% |
| 2003-12-31 | $0.61 B | 1.67% |
| 2002-12-31 | $0.60 B | -9.08% |
| 2001-12-31 | $0.66 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 41,996.51% | 🇺🇸 USA |
 Pfizer PFE | $226.50 B | 56,805.08% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 24,308.53% | 🇺🇸 USA |
 Baxter BAX | $28.27 B | 7,003.93% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 26,700.54% | 🇺🇸 USA |
 AstraZeneca AZN | $102.29 B | 25,599.63% | 🇬🇧 UK |
 Richardson Electronics RELL | $0.19 B | -51.36% | 🇺🇸 USA |
 Alkermes ALKS | $2.13 B | 436.69% | 🇮🇪 Ireland |